Calcium Gluconate
Active ingredient: Calcium Gluconate Monohydrate
In short: Calcium Gluconate Injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. Limitations of Use The safety of Calcium Gluconate Injection for long term use has not been established.
What is Calcium Gluconate used for?
Calcium Gluconate Injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia.
Limitations of Use
The safety of Calcium Gluconate Injection for long term use has not been established.
Calcium Gluconate dosage
2.1 Important Administration Instructions
Calcium Gluconate Injection contains 100 mg of calcium gluconate per mL which contains 9.3 mg (i.e., 0.465 mEq) of elemental calcium.
Dilute Calcium Gluconate Injection prior to use in 5% dextrose or normal saline and assess for potential drug or IV fluid incompatibilities .
Inspect Calcium Gluconate Injection visually prior to administration. The solution should appear clear and colorless to slightly yellow. Do not administer if there is particulate matter or discoloration.
Use the diluted solution immediately after preparation.
Administer Calcium Gluconate Injection intravenously via a secure intravenous line to avoid calcinosis cutis and tissue necrosis .
Administer Calcium Gluconate Injection by bolus administration or continuous infusion:
For bolus intravenous administration:
Dilute the dose of Calcium Gluconate Injection in 5% dextrose or normal saline to a concentration of 10-50 mg/mL prior to administration. Administer the dose slowly and DO NOT exceed an infusion rate of 200 mg/minute in adults or 100 mg/minute in pediatric patients, including neonates. Monitor patients, vitals and electrocardiograph (ECG) during administration .
For continuous intravenous infusion:
Dilute Calcium Gluconate Injection in 5% dextrose or normal saline to a concentration of 5.8-10 mg/mL prior to administration. Administer at the rate recommended in Table 1 and monitor patients, vitals, calcium and ECG during the infusion .
Calcium Gluconate Injection is supplied in single-dose vials.
2.2 Recommended Dosage
Individualize the dose of Calcium Gluconate Injection within the recommended range depending on the severity of symptoms of hypocalcemia, the serum calcium level, and the acuity of onset of hypocalcemia.
Table 1 provides dosing recommendations for Calcium Gluconate Injection in mg of calcium gluconate for neonates, pediatric and adult patients.
Table 1. Dosing Recommendations in mg of Calcium Gluconate for Neonate, Pediatric, and Adult Patients
2.3 Serum Calcium Monitoring
Measure serum calcium every 4 to 6 hours during intermittent infusions with Calcium Gluconate Injection and measure serum calcium every 1 to 4 hours during continuous infusion.
2.4 Dosage in Renal Impairment
For patients with renal impairment, initiate Calcium Gluconate Injection at the lowest dose of the recommended dose ranges for all age groups and monitor serum calcium levels every 4 hours.
2.5 Drug Incompatibilities
Do not mix Calcium Gluconate Injection with ceftriaxone. Concurrent use of intravenous ceftriaxone and Calcium Gluconate Injection can lead to the formation of ceftriaxone-calcium precipitates. Concomitant use of ceftriaxone and intravenous calcium-containing products is contraindicated in neonates (28 days of age or younger) . …
How to take Calcium Gluconate — instructions & advice from the label
•Advise the patient that the risks associated with infusion including local tissue inflammation, local necrosis and calcinosis. .
Manufactured for:
Nivagen Pharmaceuticals Inc.
Sacramento, CA 95827 USA
Distributed by:
Hikma Pharmaceuticals USA Inc.
Berkley Heights, NJ 07922
Rev. 05/2023
Warnings & precautions
Do not take this medicine if: Calcium Gluconate Injection is contraindicated in:
Hypercalcemia
Neonates (28 days of age or younger) receiving ceftriaxone
5.1 Arrhythmias with Concomitant Cardiac Glycoside Use
Cardiac arrhythmias may occur if calcium and cardiac glycosides are administered together. Hypercalcemia increases the risk of digoxin toxicity. Administration of Calcium Gluconate Injection should be avoided in patients receiving cardiac glycosides. If concomitant therapy is necessary, Calcium Gluconate Injection should be given slowly in small amounts and with close ECG monitoring .
5.2 End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates
Concomitant use of ceftriaxone and Calcium Gluconate Injection is contraindicated in neonates (28 days of age or younger) due to cases of fatal outcomes in neonates in which a crystalline material was observed in the lungs and kidneys at autopsy after ceftriaxone and calcium were administrated simultaneously through the same intravenous line. Concomitant administration can lead to the formation of ceftriaxone-calcium precipitates that may act as emboli, resulting in vascular spasm or infarction .
In patients older than 28 days of age, ceftriaxone and Calcium Gluconate Injection may be administered sequentially, provided the infusion lines are thoroughly flushed between infusions with a compatible fluid. Do not administer Ceftriaxone simultaneously with Calcium Gluconate Injection via a Y-site in any age group.
5.3 Tissue Necrosis and Calcinosis
Intravenous administration of Calcium Gluconate Injection and local trauma may result in calcinosis cutis due to transient increase in local calcium concentration. …
Calcium Gluconate side effects
The following serious adverse reactions are also described elsewhere in the labeling:
Arrhythmias with Concomitant Cardiac Glycoside Use
End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates
Tissue Necrosis and Calcinosis
Hypotension, Bradycardia, and Cardiac Arrhythmias
Aluminum toxicity
The following adverse reactions associated with the use of calcium gluconate were identified in the literature. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency reliably or to establish a causal relationship to drug exposure.
Cardiovascular:
Vasodilation, decreased blood pressure, bradycardia, cardiac arrhythmia, syncope, cardiac arrest
Administration site reactions:
Local soft tissue inflammation, local necrosis, calcinosis cutis and calcification due to extravasation
Drug interactions
7.1 Cardiac Glycosides
Hypercalcemia increases the risk of digoxin toxicity, while digoxin may be therapeutically ineffective in the presence of hypocalcemia. Synergistic arrhythmias may occur if calcium and cardiac glycosides are administered together. Avoid administration of Calcium Gluconate Injection in patients receiving cardiac glycosides; if considered necessary, administer Calcium Gluconate Injection slowly in small amounts and monitor ECG closely during administration.
7.2 Calcium Channel Blockers
Administration of calcium may reduce the response to calcium channel blockers.
7.3 Drugs that may cause Hypercalcemia
Vitamin D, vitamin A, thiazide diuretics, estrogen, calcipotriene and teriparatide administration may cause hypercalcemia. Monitor plasma calcium concentrations in patients taking these drugs concurrently.
About this medicine
Calcium Gluconate Injection, USP is a clear, colorless to slightly yellow, sterile, preservative-free, nonpyrogenic, supersaturated solution of calcium gluconate, a form of calcium, for intravenous use.
Calcium Gluconate is calcium D-gluconate (1:2) monohydrate. The structural formula is:
Molecular formula: C12H22CaO14• H2O
Molecular weight: 448.39
Solubility in water: 3.5 g/100 mL at 25°C
Calcium Gluconate Injection, USP is available as 1,000 mg per 10 mL (100 mg per mL) in a single-dose vial.
Each mL of Calcium Gluconate Injection, USP contains 100 mg of calcium gluconate (equivalent to 94 mg of calcium gluconate and 4.5 mg of calcium saccharate tetrahydrate), hydrochloric acid and/or sodium hydroxide for pH adjustment (6.0 to 8.2) and water for injection, q.s. It contains no antimicrobial agent.
Each mL of Calcium Gluconate Injection, USP contains 9.3 mg (0.465 mEq) of elemental calcium.
How it works: 12.1 Mechanism of Action Intravenous administration of calcium gluconate increases serum ionized calcium level. Calcium gluconate dissociates into ionized calcium in plasma. …
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 3cbf6bf7-2415-4435-b3df-41855514a05d. Read the full official label on DailyMed.